Trk receptor tyrosine kinases: A bridge between cancer and neural development

Cancer Letters

Volumn 169, Issue 2, 2001, Pages 107-114

  Nakagawara, Akira ^a  

^a CHIBA CANCER CENTER   (Japan)

Author keywords

Neuroblastoma; Protooncogene; Trk receptor tyrosine kinases

Indexed keywords

NERVE GROWTH FACTOR; NEUROTROPHIN; PROTEIN P53; PROTEIN P73; PROTEIN TYROSINE KINASE;

APOPTOSIS; CANCER INHIBITION; CARCINOGENESIS; CELL DEATH; CELL TRANSFORMATION; CELL TYPE; COLON CARCINOMA; ENZYME ACTIVITY; GENE ACTIVATION; GENE REARRANGEMENT; GROWTH REGULATION; HUMAN; MEDULLOBLASTOMA; NERVE CELL DIFFERENTIATION; NERVE CELL NETWORK; NEUROBLASTOMA; ONTOGENY; PRIORITY JOURNAL; PROTO ONCOGENE; RECEPTOR AFFINITY; SHORT SURVEY; THYROID CARCINOMA;

EID: 0035964486     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00530-4     Document Type: Review

References (40)

1. The nerve growth factor 35 years later
2. The trk protooncogene encodes a receptor for nerve growth factor
3. High-affinity NGF binding requires coexpression of the trk protooncogene and the low-affinity NGF receptor
4. Gene transfer and molecular cloning of the human NGF receptor
5. Functions of the neurotrophins during nervous system development: What the knockouts are teaching us
6. Role of neurotrophins in mouse neuronal development
7. The trk family of tyrosine protein kinase receptors
8. Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25)
9. Identification and characterization of an activating TrkA deletion mutation in acute myeloid leukemia
10. TrkA immunoglobulin-like ligand binding domains inhibit spontaneous activation of the receptor
11. Fusion of EIV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25)
12. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas
13. Association between high levels of expression of the IRK gene and favorable outcome in human neuroblastoma
14. SeegerLack of high-affinity nerve growth factor receptors in aggressive neuroblastomas
15. Coexpression of messenger RNA for IRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis
16. The NGF Story and Neuroblastoma
17. Expression and function of TRK-B and BDNF in human neuroblastomas
18. 4STrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells
19. Expression of IRK-C in favorable human neuroblastomas
20. Molecular basis of spontaneous regression of neuroblastoma: Role of neurotrophic signals and genetic abnormalities
21. Up-regulation of insulin-like growth factor-TI expression is a feature of TrkA but not IrkB activation in SH-SY5Y neuroblastoma
22. Glial cell line-derived neurotrophic factor/neurturin-induced differentiation and its enhancement by retinoic acid in primary human neuroblastomas expressing c-Ret, GFRα-1 and GFRα-2
23. Expression of the neurotrophin receptor IrkC is linked to a favorable outcome in medulloblastoma
24. Apoptotic pathway induced by nerve growth factor-mediated TrkA activation in medulloblastoma
25. Roles of trk family neurotrophin receptors in medullary thyroid carcinoma development and progression
26. HER2 in activating growth of human breast carcinoma cells
27. Irks: Signal transduction and intracellular pathways
28. Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells
29. An anti-apoptotic role for the p53 family member, p73, during developmental neuron death
30. p73 at chromosome lp36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent
31. p53 is essential for developmental neuron death as regulated by the TrkA and p75 neurotrophin receptors
32. 73 in a neuroblastoma cell line
33. Association of the Abl tyrosine kinase with the Irk nerve growth factor receptor
34. Mediation of nerve growth factor-driven cell cycle arrest in PC12 cells by p53 - Simultaneous differentiation and proliferation subsequent to p53 functional inactivation
35. Direct transactivation of c-Ha-Ras gene by p53: Evidence for its involvement in p53 transactivation activity and p53-mediated apoptosis
36. Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors
37. NTR
38. 1d2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins
39. Surfing the p53 network
40. Opposing effects of Ras on p53: Transcriptional activation of mdm2 and induction of p19ARF